Maine Medical vs Adult‑Use Cannabis: Testing, Labels, Players

Close-up of a printed Maine statutory page and an OCP guidance booklet laid side by side on a wooden table, with a pen and a small sample bag of dried flower nearby. — **Educational visual context**
Documentary still showing the two legal paths: a printed excerpt of the Maine Medical Use statute next to an OCP testing guidance pamphlet. This image is intended to teach how the statutes and administrative guidance sit side‑by‑side; it is not a record of any individual product or lab result. Source documents: Maine OCP medical program page and the Maine legislature statute. (Limit: does not display any readable COA numbers or logos.)

Published: September 26, 2026

Quick map — what this is and what it isn’t

This article draws a practical, dated map of Maine’s two distinct cannabis programs as they exist on September 26, 2026. It explains who the players are, how testing and lab reporting work, how labels are built, and why program identity matters in the real world of growers, caregivers, dispensaries, and everyday adults. Where I summarize rules or lab practice I link the primary Maine statutes, OCP guidance, and national measurement resources so you can follow the paperwork yourself. (maine.gov)

This is education, not legal or medical advice. The rules and guidance change; I note the sources and dates so you can check for updates before making decisions.

Infographic map of program participants showing 'Qualifying Patients & Caregivers' and 'Adults 21+' pathways with separate boxes for 'Dispensary/Store' and 'Caregiver/home' — schematic only. — **Look closer**
A clear, non‑numeric diagram showing the different participant pathways in Maine’s two programs: registered qualifying patients and caregivers versus adult consumers and licensed stores. The diagram explains program identity visually; it does not provide municipal filing or local license maps. Source: Maine OCP program overview. (Limit: schematic only, not legal advice.)
Research context: Maine Medical Use of Cannabis Program · Adult Use Rules and Statutes (Title 28‑B)

Who participates and why the distinction exists

Maine runs two programs in parallel: the Maine Medical Use of Cannabis Program (MMCP) and an Adult Use Cannabis Program (AUCP). The MMCP is built on Title 22, Chapter 558‑C and the OCP’s medical pages; it operates with a registry and qualifying‑patient framework. The AUCP is governed by Title 28‑B and separate adult‑use rules. That split is intentional: the statutes and rules create different participant types (qualifying patients and caregivers versus adult consumers and licensed adult‑use businesses) and different regulatory responsibilities. ()

Questions this guide answers

Are Maine’s medical and adult‑use cannabis programs the same?

No. They are separate by statute and rule. The medical program (Title 22) uses a patient registry and qualifying pathways; the adult program (Title 28‑B) governs sales to adults 21+ and has its own licensing, testing, and labeling requirements. ([legislature.maine.gov](https://www.legislature.maine.gov/legis/statutes/22/title22ch558-C.pdf))

What is a COA and why should I look at it?

A Certificate of Analysis (COA) is the lab report tied to a specific batch. It shows which tests were performed and the results. Matching a product’s batch ID to its COA is essential because labels alone don’t prove contaminant testing. ([maine.gov](https://www.maine.gov/dafs/ocp/sites/maine.gov.dafs.ocp/files/2023-10/Understanding%20Maine%20Cannabis%20Testing%20Requirements%20%26%20Results.pdf))

Do all Maine cannabis products get the same tests?

Not always. Adult‑use products are subject to mandatory analyte lists set by OCP and statute; medical products and research samples may follow different sampling or investigatory testing procedures. Check OCP guidance for the current rules. ([legislature.maine.gov](https://legislature.maine.gov/statutes/28-b/title28-Bsec601.html))

How does NIST help with cannabis testing?

NIST develops reference materials, inter‑lab exercises (CannaQAP), and measurement methods to improve accuracy and comparability across labs. That work helps regulators and labs interpret COA results more reliably. ([nist.gov](https://www.nist.gov/publications/cannabis-laboratory-quality-assurance-program-exercise-2-cannabinoid-final-report))

Where can I find the official Maine rules and guidance?

Primary sources are the OCP pages and the Maine Revised Statutes: Maine OCP’s medical and adult‑use pages and Title 22 (medical) and Title 28‑B (adult use) on the legislature site. Always check the date on guidance documents. ([maine.gov](https://www.maine.gov/dafs/ocp/medical-use))

Educational information only. Cannabis affects people differently and this is not medical advice.

Testing: what Maine requires and why lab standards matter

Maine’s adult‑use statute directs the OCP to establish a testing program and identify the contaminants and maximum allowable levels of those contaminants. Mandatory testing applies to many adult‑use items; the OCP has published required analyte lists and guidance showing which contaminants (pesticides, heavy metals, microbial hazards, residual solvents, water activity, and filth) must be tested and reported. Medical program testing is governed by its statutes and OCP rules and may differ in procedures, sampling, or investigative testing authorities. (legislature.maine.gov)

The certificate of analysis (COA) is central: it’s the lab report showing which tests were run, the methods used (when provided), and the results for that specific batch. OCP guidance tells customers to check COA dates, batch IDs, and what tests were run — a potency number alone does not tell you whether a product passed contaminant screening. For adult‑use licensees, mandatory tests must be reported to OCP within two business days via COAs and electronic data deliverables. (maine.gov)

Behind those state rules is national measurement work: NIST runs measurement research, reference materials, and the Cannabis Laboratory Quality Assurance Program (CannaQAP) to improve comparability between labs. That work matters because analytical techniques (different instruments and methods) can produce variable results; reference materials and inter‑lab exercises reduce that variability and make COAs more comparable across labs. For Maine growers and testers, NIST tools and guidance are a technical backstop to state certification rules. (nist.gov)

Close macro photograph of a printed Certificate of Analysis (COA) header showing the sample ID field only (blurred numbers) and column headings like 'Analyte' and 'Result' but no readable numeric values.

Look closer

Macro educational photo of a COA header to teach what a COA looks like without showing results or identifying information. Use this to show where batch IDs and test panels appear and to explain why matching COA batch IDs to product labels is important. (Limit: intentionally blurred values and no lab identifiers.)

Research context: Understanding Cannabis Testing Requirements & Results in Maine (OCP guide, 2023)

Mapping Maine’s Two Cannabis Programs: Medical vs. Adult‑Use (Sept 26, 2026)

Quick map — what this is and what it isn’t

Who participates and why the distinction exists

Questions this guide answers

Licenses, places, and the rule against mixing markets

Testing: what Maine requires and why lab standards matter

Labels, COAs, and what the consumer sees (and doesn’t)

Why program identity matters in practice — supply chains, access, and safety

How to read a COA and a Maine label — practical steps (without medical advice)

Bottom line for growers, caregivers, patients, and adults